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What’s already known about this topic 
 A high number of acquired melanocytic naevi, the red hair phenotype, and MC1R R 
alleles all independently increase melanoma risk. 
 Women with atypical naevi have a rising melanoma risk gradient from darker hair to 
lighter hair. 
 Women with many naevi have a rising melanoma risk gradient from those with no 
elements of the red hair phenotype, to those with freckles but not red hair, to those with 
red hair.  
What does this study add? 
 In Queensland, people with 20+ naevi (≥5mm diameter) and MC1R R/R genotype have a 
25-fold increased melanoma risk, relative to people with 0-4 naevi and MC1R WT/WT 
genotype. 
 In Queensland, individuals with 20+ naevi and MC1R R/R genotype have an absolute 
melanoma risk to age 75 of 23.3% for men and 19.3% for women. 
 This effect is independent of CDKN2A genotype. Further research is required to 
determine the effect of lower incident UV settings, as this study took place in the very 
high incident UV environment of Queensland, Australia. 
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 MC1R R/r genotype is associated with increased total body naevus count; this is not the 
case for R/R. 
What is the translational message? 
 Patients with many large naevi and the red hair colour phenotype, particularly those with 
an MC1R R/R genotype, have an unusually high risk of melanoma. In a high UV 
environment this risk exceeds the threshold recommended for screening in other cancers, 
and such individuals should undergo intensive, regular physician-led surveillance. 
 Patients with many large naevi with non-red colour hair may benefit further from clinical 
MC1R genotyping. 
 
Summary 
Background: A high total body naevus count is the highest risk factor for melanoma; the red 
hair colour phenotype of red hair, freckling and pale skin that burns easily, produced by MC1R R 
alleles, also predisposes to melanoma.  
Objective: To determine whether the known melanoma risk factors of high naevus count and red 
hair or MC1R R alleles act synergistically to increase melanoma risk. 
Methods: The Brisbane Naevus Morphology Study drew 1267 participants from volunteers 
presenting at a melanoma unit, dermatology outpatient clinic, private dermatology clinics, 
Brisbane Longitudinal Twin Study and QSkin study. We examined pigmentation characteristics, 
total body naevus ≥5mm count, and MC1R, ASIP and CDKN2A genotype in participants with 
and without a personal history of melanoma, living in the very high incident UV setting of 
Queensland, Australia.  
Results: Cases were older than controls (median 57 vs 33 years). Compared to individuals with 
dark brown hair and 0-4 naevi, individuals with red hair and 20+ naevi had a melanoma OR 10.0 
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(95%CI 4.2-24.3). Individuals with MC1R R/R genotype and 20+ naevi ≥5mm had a melanoma 
OR 25.1 (95%CI 8.4-82.7) compared to WT/WT individuals with 0-4 naevi. The highest risk 
group, Australian men with MC1R R/R genotype and 20+ moles, had an absolute risk of 
melanoma to age 75 of 23.3%, compared to 0.8% for men with WT/WT genotype and 0-4 naevi. 
Conclusions: Patients living in a high incident UV setting with many large naevi and the red 
hair colour phenotype, particularly those with MC1R R/R genotype, have a high risk of 
melanoma above the threshold recommended for screening in other cancers and should undergo 
intensive physician-led surveillance. 
 
Keywords: melanocortin-1 receptor, MC1R, naevi, melanoma, pigmentation, RHC phenotype 
 
Abbreviations 
BLTS, Brisbane Longitudinal Twin Study 
BNMS, Brisbane Naevus Morphology Study 
GEM, Genes, Environment and Melanoma study 
OR [95%CI], odds ratio [95% confidence interval] 
MC1R, melanocortin-1 receptor 
RHC, red hair colour 
TNC, total naevus count  
TNC5, total count of naevus ≥5mm   
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INTRODUCTION 
A high number of acquired melanocytic naevi is the strongest known phenotypic risk factor for 
melanoma; individuals with the highest numbers of naevi have a 5 to 10-fold increase in 
melanoma risk,
1
 and this is associated with younger age at diagnosis.
2
 Total body naevus count 
(TNC) is highly heritable (h
2
=60-70%),
3
 and strongly influenced by genetic polymorphisms 
within or near IRF4, MTAP, PLA2G6, and MITF.
4
 High sun exposure levels are also associated 
with the development of more naevi.
5
 While it has been suggested that this high naevus 
phenotype is associated with darker pigmentation, most studies have associated high TNC with 
paler or sun-sensitive pigmentation. Interestingly, TNC in red-haired juveniles and adolescents 
have been reported to be significantly lower than in individuals with pale-pigmentation and other 
hair colours.
6
 
Melanoma risk is also elevated in individuals with pale skin, hair and eye pigmentation. The 
melanocortin-1 receptor (MC1R) gene is a well-known pigmentation and melanoma risk gene.
4
 
Melanoma risk is elevated approximately 4-fold in individuals with the red hair colour (RHC) 
ph notype, caused by highly penetrant variants in MC1R.
7
 This G-protein coupled receptor is 
expressed on the surface of melanocytes and transduces signals controlling the production of 
UV-protective eumelanin, which absorbs UV rays, prevents photo-carcinogenesis, and is visible 
as tanned skin. MC1R is highly polymorphic in European-ancestry populations, with around 200 
identified variants including many full- or partial-loss-of function variants.
8
 The most common 
alleles strongly associated with the RHC phenotype, designated R alleles, are D84E, R142H, 
R151C, R160W and D294H. Alleles that are moderately penetrant for RHC, designated r alleles, 
include V60L, V92M, I155T and R163Q.
8, 9
 These variants lead to decreased intracellular 
signalling and subsequent lack of eumelanin resulting in the RHC phenotype, characterized by 
red hair, freckles and pale, easily-sunburned skin that does not tan well.
9
 High levels of 
freckling, but reduced numbers of naevi, have been associated with this phenotype in 
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adolescents.
6
 RHC is a recessive genetic trait usually requiring two R variant alleles; however, 
carrying one R allele can also result in reduced pigmentation and/or increased sun sensitivity. 
Variation at the Agouti signalling protein locus (ASIP) also contributes to the red hair 
phenotype
10
 – ASIP is an MC1R competitive inhibitor.  
When melanoma is detected while it is still localized and thin, survival rates are excellent (95%), 
but prognosis worsens with increasing tumour thickness at diagnosis and is poor for tumours that 
have spread regionally and to distal organs.  While melanoma is not common enough to warrant 
regular screening of the general population, physician-based screening for high-risk groups is 
recommended by several national guidelines
11
 and can improve the chances of early detection 
and reduce the necessity for high-cost extensive treatment. Intensive screening of high-risk 
patients can also improve the benign to malignant ratio of excisions.
12
 
The presence of reciprocal melanoma risk phenotypes – many naevi/darker pigmentation and 
few naevi/paler pigmentation – suggest that there are two pathways to melanoma formation, one 
involving an elevated tendency to melanocytic proliferation, and the other an elevated risk of 
DNA damage by UV exposure.
13
 However, a study by the GEM consortium found that there was 
no significant association between a phenotypic index (incorporating hair and eye colour and 
tanning phenotype) and the number of naevi,
2
 indicating that it is possible for individuals to have 
risk factors for both pathways. A study of Scandinavian women found a super-multiplicative 
effect of red hair and multiple large asymmetric naevi, suggesting an important gene-gene 
interaction involving MC1R in melanoma aetiology.
14
 This study found that women with ≥2 
large asymmetric naevi had a melanoma risk gradient rising from 1.72 (95%CI 1.03-2.89) with 
brown or black hair to 3.30 (95%CI 2.15-5.06) with blonde hair to 4.95 (95%CI 1.88-13.01) with 
red hair. Another meta-analysis of 10 case-control melanoma studies in Australia, Denmark, the 
UK and the USA found that women in the highest quartile of naevus counts had a melanoma OR 
of 4.5 (95%CI 1.3–15.7) when they had neither red hair not freckles, rising to 7.3 (95%CI 2.7–
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19.7) when they had freckles but not red hair, and 14.4 (95%CI 2.0-102.0) when they had red 
hair.
15
 However, these studies have not combined MC1R genotype and naevus count in both men 
and women to assess melanoma risk. This paper examines individuals of both sexes for traits of 
both pathways and find they have a higher melanoma risk than those with high TNC or MC1R 
risk genotypes alone.  
 
MATERIALS AND METHODS 
Study population  
This study was approved by the Metro South Human Research Ethics Committee (approval 
#HREC/09/QPAH/162, 26 August 2009) and The University of Queensland (approval 
#2009001590, 14 October 2009) and conducted in accordance with the Declaration of Helsinki. 
Participants provided written consent after receiving a Participant Information and Consent 
Form. Participants under 18 years of age also required the written consent of a parent or 
guardian. 
1267 individuals volunteered for clinical examination from October 2009 to November 2016 as 
part of the Brisbane Naevus Morphology Study (BNMS), an epidemiological study of naevus 
and melanoma genes in participants recruited from South-East Queensland.
16
 Recruiting was via 
the Melanoma Unit and Dermatology Department of the Princess Alexandra Hospital (Brisbane, 
Australia), private dermatology clinics, the Brisbane Longitudinal Twin Study (BLTS)
3
 and the 
QSkin Study.
17
 611 case participants had a personal history of one or more primary melanomas, 
verified by histopathological report, the referring dermatologist or attendance at the Melanoma 
Unit. 656 unaffected control participants had no personal history of melanoma at time of 
recruitment, as reported by the participant, and were predominantly drawn from the BLTS and 
QSkin representative of the phenotypic distribution of the Queensland population. A pilot study 
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established that a maximum of 200 participants could be assessed per year. The study length was 
determined by funding constraints.   
 
Data Collection 
Participants completed a questionnaire regarding demographic information, sun exposure 
history, sun sensitivity, and medical history. They reported their natural hair colour at the age of 
21 years and gave a saliva sample for DNA extraction. A trained research assistant recorded the 
participant’s height, weight, eye and skin colour, and degree of skin freckling on the face, 
shoulders, and dorsal hands. Count of large melanocytic naevi (≥5mm) was made from high 
quality full body images.
16
 Statistical analysis was conducted the R statistical computing 
environment.
18
 See Supporting Information. 
 
RESULTS 
There were 1267 study participants, with 611 melanoma cases and 656 unaffected controls 
eligible for the present analysis, 1235 with complete genotype data. Of the case participants, 275 
(47%) had multiple primary melanomas (Fig S1). Participants were predominantly of European 
ancestry, with a minority of Asian or Pacific background. The median age at phenotypic 
evaluation of all participants was 47yr (range 11 to 88), with men slightly older than women. 
Cases were older than controls with a median of 57yr (14 to 88) vs 33yr (11 to 76). Body mass 
index was significantly higher in cases than controls (28.2 vs 25.1; P<10
-6
), possibly due to the 
older average age of the case group. Red hair (P=10
-5
), blue/grey eyes (P=7x10
-5
), fair skin 
(P=0.015) and a high freckling score (P<10
-6
) were associated with melanoma risk. High total 
count of naevus ≥5mm (TNC5) was strongly associated with melanoma risk, with cases having a 
significantly higher TNC5 than controls (mean 32.5 vs 13.4 large naevi; P<10
-6
). 
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There were 145 (11.8%) individuals with red hair in the BNMS collection with MC1R genotypes 
determined, 46 (7.2%) in control and 99 (16.9%) in the cases (Table S1). After stratifying on 
case status, red hair was significantly associated with TNC5 (P=0.003). This was most notable in 
control participants but the interaction with case status was not significant (P=7x10
-4
 vs P=0.41, 
respectively; Table S2); cases had a high TNC5 irrespective of hair colour. The mean TNC5 of 
20.7 for red hair controls was lower than any case hair colour mean TNC5, but the red hair mean 
TNC5 at 35.5 for cases was the highest of any hair colour.   
MC1R genotypes were grouped as WT (wild type consensus sequence), r (V60L, V92M, I155T, 
R163Q) or R (D84E, R142H, R151C, R160W, D294H, any frame shift or insertion variant 
allele). As expected, R alleles were significantly associated with red hair (Tables S1, S3, S4) and 
melanoma risk (Table S5; R allele melanoma OR 2.02, 95%CI 1.6-2.5). MC1R genotypes were 
associated with TNC5 (Fig. S2; Tables S6, S7), consistent with two previous reports,
19, 20
 with 
the R/r genotype having the greatest mean TNC5 of 19 and 39 in the respective control and case 
groups. When testing the effects of each MC1R genotype in turn, only the R/r combination was 
significantly associated with a higher TNC5 (Table S8, P=4x10
-6
), with the genotypic model 
resulting in a significantly better fit than an allelic model assuming allele effects are additive. 
The association of the ASIP locus with hair colour was investigated via the rs910873*G/A SNP, 
which alters ASIP expression and has previously been associated with melanoma. The A/A 
homozygote increased the OR for red hair 39-fold (Tables S4, S9). The largest hair colour effect 
of ASIP genotype was seen in combination with the R/r and WT/R genotypes (Fig. S3). 
There was a striking increase in melanoma risk when the RHC phenotype was combined with 
high naevus count (Table 1, Fig. 1a). Compared to individuals with dark brown hair and 0-4 
TNC5, individuals with red hair and 20+ naevi had a melanoma OR 10.0 (95%CI 4.2-24.3). 
Stronger associations were seen when hair colour was replaced by MC1R genotype. In 
individuals with less than five large naevi, the MC1R R/R genotype increased risk of melanoma 
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4.4 fold (1.2-16.1; Table 2, Fig. 1b) when compared to an MC1R WT/WT individual with 0-4 
naevi. By contrast, an individual with R/R genotype and 20+ naevi had a melanoma OR of 25.1 
(8.4-82.7). Those MC1R WT/WT participants with 20+ naevi had a significant increase in risk 
with OR 4.8 (95%CI 1.9-12.6), with the r allele also raising the risk in the WT/r genotype OR 
11.4 (95%CI 5.0-27.9), and in the homozygous r/r state OR 6.4 (95%CI 2.2-19.8).  In general, 
for each MC1R genotype class there was a step-wise increase in OR for melanoma for each rise 
in naevus quartile, and this is independent of CDKN2A mutation carrier status (data not shown). 
The average lifetime risk to men and women in Queensland for melanoma is 1 in 17 (6%) and 1 
in 24 (4%) aged 75.
21
 Based on our comparison of cases’ and controls’ MC1R status and naevus 
count, we estimated an absolute melanoma risk to age 75 of 23.3% for men and 19.3% for 
women with TNC5 20+ and R/R genotype (Table 3, Fig. 2). By contrast, absolute risk to age 75 
with 0-4 naevi and WT/WT MC1R was 0.8% for men and 0.7% for women. The effect of TNC5 
alone can be seen by the WT/WT MC1R genotype rising to 5.0% for men and 4.0% for women 
with TNC5 20+. The supra-additive effects of TNC5 for both R and r alleles can be seen by the 
step wise increase in risk of the genotype combinations for each quartile of TNC5 (Table 3, Fig. 
2), with the most synergistic effect being TNC5 20+ and R/R genotype (synergy index = 3.19 
95%CI 1.01-10.07). The attributable proportion of all melanoma cases in Queensland to age 75 
that come from categories of TNC5 quartile and MC1R genotype are show in Table S10. 55% of 
all cases come from the upper quartile of naevus counts, with majority of these (60%) carrying 
an R allele. Notably, 33% of cases comes from just 11.1% (Table 3) of the general population. 
MC1R genotype is a superior risk predictor than hair colour (Fig. S4), apart from red hair and 
R/R which as expected are equivalent. Plots comparing the predicted cumulative proportion of 
melanoma cases attributable to hair colour, MC1R genotype, TNC5, combined hair colour + 
TNC5 and MC1R genotype + TNC5 show that MC1R contributes additional discrimination 
above that of TNC5 alone (Fig. S5). 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
DISCUSSION 
The predictive value of pigmentation phenotype for melanoma risk has long been established, 
including skin type, hair colour, degree of cutaneous freckling, TNC, and more recently iris 
pigmented lesions. Apart from age, the two strongest phenotypic risk factors are the number of 
acquired melanocytic naevi and red hair colour, but the combination of these risk phenotypes
14, 
15
 have not been thoroughly investigated. Many genes contribute to TNC and melanoma 
development, with polymorphisms in 32 chromosomal regions identified as having associated 
risk at the genome wide significant level.
22
 The predictive value of phenotypic risk can now be 
complemented with these common SNP genotypes to extend the quantitation of risk at a 
population level.
23
  However, most of the increase in genetic predictive value was explained by 
variation within the MC1R gene which has a major influence on melanogenesis (RHC 
phenotype) and DNA repair. MC1R variants are particularly useful in explaining the higher 
melanoma risk evident in some individuals who do not have an obvious high risk pigmentation 
phenotype.
24
 
It has been proposed that there are two divergent pathways to melanoma: many naevi/darker 
pigmentation, with an elevated level of melanocytic proliferation, or few naevi/paler 
pigmentation, with a greater propensity for DNA damage by UV exposure.
13
 This model has 
been supported by a number of studies, but is recognised as an oversimplification. Indeed many 
melanoma patients have elements of both risk types, consistent with the GEM Study’s finding 
that there was no significant association between a pigmentation index and number of naevi.
2
 
Elements of one risk type can also influence the development of elements from the other risk 
type. Investigations into the association of pigmentary phenotype and number of naevi have 
been variable, with some finding an association with lighter phenotypes, some with darker 
phenotypes, and some finding no association with any pigmentary phenotype.
2
 MC1R genotype 
has not been significantly associated with naevus count in many studies, with the exception of 
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the R/r combined genotype
19, 20
 reported to increase TNC as also seen in this study; in contrast, 
many studies have found that UV exposure appears to increase naevus counts. An unexpected 
result arising from our analysis, given the report of lower TNC in red haired children and 
adolescents,
6
 is that those with red hair had the highest mean TNC5 both in unaffected and 
melanoma cases. A change in TNC dependent upon genotype has also previously been reported 
for the IRF4 gene,
25
 however when TNC is considered by MC1R genotype this situation 
becomes more complex. R/R individuals who have the highest penetrance for red hair (74.3 %, 
Table S1) do not have the highest mean TNC5. Instead, the R/r genotype group in both the cases 
and unaffected controls has the highest mean TNC5 (Table S6). It must be noted that this 
genotype represents 33.1% of those with red hair in our study despite the R/R genotype 
representing the greatest proportion at 53.8% (Table S3). 
The primary goal of this study was to examine the risk of melanoma associated with TNC5, 
pigmentation traits and MC1R variant genotypes. As expected, each of these measures were 
independently associated with melanoma risk; however, the high-risk RHC phenotype or R/R 
MC1R genotype and high-risk naevus counts also contribute more than additively to predict an 
even higher melanoma risk. Melanoma incidence continues to increase worldwide and around 
15% of melanomas are fatal.
26
 Melanoma mortality is low when the tumour is detected while it 
is still localized and thin, but is poor for tumours that have spread.
11
 While regular screening of 
the general population is not recommended, several national bodies do recommend physician-
led screening for people in high risk groups,
11
 as this approach can improve the benign-to-
malignant ratio of excisions, improve early detection rates, and reduce overall costs by 
preventing the need for high-cost treatment of metastatic melanoma.
12
 Therefore, it is important 
to identify patients at particularly high risk of melanoma who can benefit from specialized 
surveillance programs with simple predictive algorithms based on quantitative data. The 
provision of MC1R genotype has already been studied in a diverse primary care setting,
27
 but 
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this is more applicable to high melanoma risk populations with differences between males and 
females to be expected. 
The location of our study, Queensland Australia, has one of the highest rates of melanoma in the 
world, with an annual incidence of 72 per 100,000 due to a combination of a high proportion of 
residents with European ancestry and consistently high UV levels.
28
 This is similar to the white 
populations in New Zealand and Hawaii. This high-UV environment likely amplifies the 
striking increase in melanoma risk with combined R/R and high naevus count risk factors seen 
in our study group, both by causing widespread UV damage and by promoting naevus 
formation. While this effect makes clear the synergistic increase in risk caused by high TNC and 
MC1R R/R genotype, it may also limit the application of this finding in geographic areas of 
lower solar UV in high latitudes of the Northern hemisphere. Further studies are needed to 
assess the combined risk in populations in low incident UV settings such as the UK.  
Currently in Australia, MC1R genotyping is not a routine medical practice, even for people who 
already have a high melanoma risk. Assessment of hair colour is currently the easiest way for a 
physician to assess the presence of high-risk R alleles, but is imperfect, as fair or brown-haired 
individuals often carry a combination of R or r alleles (Table S3). In our study, people with over 
twenty large naevi had similar melanoma OR in all non-black hair colours (7.23 to 9.95, Table 
1).  
CONCLUSIONS 
W  report that MC1R genotype and naevus number contribute synergistically to melanoma risk. 
While the R/R genotype, with or without the red hair phenotype, and a high naevus count are 
both strong melanoma risk factors on their own, when combined they result in an extremely high 
risk profile for melanoma. Although regular physician-performed skin checks are not 
recommended for the general population, the lifetime melanoma risk for individuals with twenty 
or more large naevi and MC1R R/R genotype are 19.3% for women and 23.3% for men based on 
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melanoma incidence in Queensland. Overall, these findings strongly suggest that these patients 
should undergo intensive surveillance for melanoma by a physician. 
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Figure legends: 
Figure 1. Melanoma OR for total naevus ≥5mm count quartiles (Q1 to Q4) for each hair colour 
and for each MC1R genotype. A) The odds ratio [95% confidence intervals] (OR [95% CI]) for 
melanoma is plotted on a logarithmic scale (y-axis, solid dots and bars) for each hair colour 
defined as black, dark brown, light brown, blonde and red (x-axis).  The OR is relative to the 
dark brown/Q1 category set to 1. B) The OR [95% CI] for melanoma is plotted on a logarithmic 
scale (y-axis, solid dots and bars) for each composite MC1R genotype (x-axis). The OR is 
relative to the WT/WT genotype/Q1 category set to 1. 
 
Figure 2. Absolute lifetime risk of melanoma to age 75 years in total naevus ≥5mm count 
quartiles for each MC1R genotype.  
The figure graphs the absolute cumulative melanoma risk (and 95% confidence intervals) to age 
75 years (y-axis) for males (squares with solid line) and females (circles with dashed line) by 
quartile of the age-sex adjusted number of naevi ≥5mm diameter (0-4, 4-10, 10-20, 20+ nevi).  
Within each quartile the composite MC1R genotype is indicated in the legend by colour. 
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Tables 
Table 1. Melanoma OR for TNC ≥5mm count quartiles for each hair 
colour 
Hair Colour Bar
a
 TNC≥5mm N Odds 
Ratio
b
 
95%CI 
Black 1 0-4 21 0.82 0.22-2.76 
2 4-10 13 0.62 0.11-2.7 
3 10-20 9 12.75 1.83-263.13 
4 20+ 14 4.17 1.04-20.14 
Dark Brown 5 0-4 74 1.00  
6 4-10 102 1.60 0.77-3.41 
7 10-20 91 2.65 1.25-5.77 
8 20+ 131 7.23 3.57-15.14 
Light Brown 9 0-4 87 1.23 0.55-2.76 
10 4-10 76 1.17 0.52-2.66 
11 10-20 106 2.33 1.12-4.96 
12 20+ 145 7.76 3.89-16.03 
Blonde 13 0-4 32 1.03 0.38-2.78 
14 4-10 54 1.36 0.57-3.29 
15 10-20 56 3.63 1.53-8.78 
16 20+ 92 8.17 3.83-18.00 
Red 17 0-4 20 2.88 0.87-9.34 
18 4-10 29 10.78 3.47-38.83 
19 10-20 36 5.86 2.24-16.15 
20 20+ 59 9.95 4.24-24.33 
a
Corresponding bar in Figure 1A. 
b
Odds ratios for melanoma are relative to the lowest quartile of Dark 
Brown, as Black hair colour is relatively uncommon in our sample set. 
OR: Odds ratio 
N: number of participants 
TNC≥5mm: total naevus count ≥5mm in diameter  
95%CI: 95% confidence intervals 
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Table 2. Melanoma OR for TNC ≥5mm count quartiles for each 
MC1R genotype 
MC1R 
genotype 
Bar
a
 TNC≥5mm N Odds 
Ratio
b
 
95%CI 
WT/WT 1 0-4 60 1.00   0   
2 4-10 65 1.27 0.50-3.33 
3 10-20 59 1.75 0.69-4.62 
4 20+ 61 4.82 1.92-12.64 
WT/r 5 0-4 71 1.09 0.43-2.83 
6 4-10 53 2.50 0.97-6.66 
7 10-20 68 3.06 1.25-7.81 
12 20+ 97 11.42 4.96-27.88 
r/r 9 0-4 18 1.25 0.28-4.88 
10 4-10 29 6.07 2.02-19.01 
11 10-20 25 6.23 2.00-20.51 
16 20+ 31 6.41 2.18-19.78 
WT/R 
 
13 0-4 41 2.61 0.94-7.39 
14 4-10 65 1.66 0.67-4.30 
15 10-20 57 4.81 1.88-12.76 
8 20+ 97 14.21 6.12-35.04 
R/r 17 0-4 21 2.69 0.72-9.99 
18 4-10 36 3.02 1.06-8.90 
19 10-20 63 6.31 2.57-16.27 
20 20+ 111 12.87 5.67-31.12 
R/R 21 0-4 19 4.42 1.24-16.12 
22 4-10 23 6.57 1.99-23.05 
23 10-20 23 11.32 3.33-41.19 
24 20+ 39 25.09 8.39-82.65 
a
Corresponding bar in Figure 1B. 
b
Odds ratios for melanoma are relative to the lowest quartile. 
Covariates are age and sex. 
OR: Odds ratio 
N: number of participants 
TNC≥5mm: total naevus count ≥5mm in diameter  
95%CI: 95% confidence intervals 
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Table 3. Absolute melanoma risk to age 75 years in TNC ≥5mm count quartiles for 
each MC1R genotype 
TNC 
≥5mma 
MC1R 
genotype 
Frequency
b
 Stratum 
OR
c
 
Multiplicative 
OR
d
 
Absolute melanoma risk
e
  
Female Male 
Q1 
 
0-4 
naevi 
WT/WT 0.076 1 1 0.007 0.008 
WT/r 0.084 1.1 1.8 0.012 0.015 
r/r 0.022 1.2 2.5 0.016 0.02 
WT/R 0.042 2.6 2.3 0.015 0.019 
R/r 0.02 2.5 2.7 0.018 0.022 
R/R 0.015 4.4 5.2 0.034 0.042 
Q2 
 
4-10 
naevi 
WT/WT 0.074 1.2 1.4 0.01 0.012 
WT/r 0.051 2.4 2.6 0.017 0.021 
r/r 0.02 6 3.6 0.023 0.029 
WT/R 0.065 1.6 3.3 0.022 0.027 
R/r 0.029 2.9 3.9 0.026 0.032 
R/R 0.012 6.4 7.5 0.049 0.06 
Q3 
 
10-20 
naevi 
WT/WT 0.06 1.7 2.4 0.016 0.02 
WT/r 0.062 3 4.3 0.028 0.035 
r/r 0.017 6.2 6 0.039 0.048 
WT/R 0.051 4.6 5.5 0.036 0.045 
R/r 0.045 6.2 6.6 0.043 0.053 
R/R 0.012 10.9 12.7 0.08 0.099 
Q4 
 
20+ 
naevi 
WT/WT 0.056 4.7 6.2 0.04 0.05 
WT/r 0.054 11.2 11.1 0.071 0.088 
r/r 0.02 6.3 15.4 0.097 0.119 
WT/R 0.046 13.9 14.2 0.09 0.11 
R/r 0.053 12.7 17 0.106 0.13 
R/R 0.012 24.2 32.4 0.193 0.233 
a
Quartile of age-sex standardized number of naevi ≥5mm diameter 
b
Frequency of MC1R genotype in each naevus quartile in BNMS control participants 
c
Odds ratio for each category of MC1R genotype and naevus quartile 
d
Odds ratio assuming MC1R genotype and naevus quartile interact multiplicatively.  The fit 
of the stratum model and the multiplicative model do not differ significantly (P=0.53) 
e
Value and 95%CI plotted in Figure 2 
OR: Odds ratio 
TNC≥5mm: total naevus count ≥5mm in diameter  
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